Iliadi-Alexandrou M E, Patramani I, Venetsanos P, Parissis N, Pavlatou M
Int J Dermatol. 1982 Nov;21(9):515-20. doi: 10.1111/j.1365-4362.1982.tb01196.x.
Although a variety of complement values have been reported in leprosy, we found no difference in the CH50 and C3 in the sera of 30 normal persons and 233 lepromatous patients. No statistically significant difference was observed in CH50 and C3 values between healthy controls and lepromatous patients taken as a whole or separated into the different types of the disease spectrum (P greater than 0.1). A statistical difference in C3 titers was found between health controls and borderline patients (P less than 0.05 greater than 0.01) but the sample number is too small to be valid. An important number of sera tested had low and an equally important number had high complement values. Sera with high and low values are important because high values are found in acute inflammatory reactions and low values demonstrate complement activation. Discrepancies in reported results are probably due not only to differences in the methods used, storage and limited number of sera tested, but mainly to the stage of the disease and the drug's administration.
虽然在麻风病中已报道了多种补体值,但我们发现30名正常人和233名瘤型麻风患者血清中的总补体活性(CH50)和C3没有差异。在将健康对照者与作为一个整体的瘤型麻风患者或按疾病谱不同类型分开的瘤型麻风患者之间,CH50和C3值未观察到统计学上的显著差异(P大于0.1)。在健康对照者与边缘型患者之间发现C3滴度有统计学差异(P小于0.05大于0.01),但样本数量太少,结果无效。检测的大量血清补体值低,同样数量的血清补体值高。补体值高和低的血清都很重要,因为高值见于急性炎症反应,低值表明补体激活。报道结果的差异可能不仅归因于所用方法、储存和检测血清数量有限的差异,主要还归因于疾病阶段和药物给药情况。